Concepedia

Janneke S. Hoogstad‐van Evert

JS

Statistics

Publications

10

Citations

472

H-Index

10

Active since

2017

Affiliations

Radboud University Medical Center(Current)

Radboud University Nijmegen

Radboud Institute for Molecular Life Sciences

University Medical Center

Amphia Ziekenhuis

Janneke S. Hoogstad‐van Evert is an author at Radboud University Medical Center specializing in oncology, cancer immunotherapy, and natural killer cell biology.

ORCID

Publications per year

2017–2024

10

Publications

10

Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients

Janneke S. Hoogstad‐van Evert, Ralph J. A. Maas, Jolien M.R. Van der Meer et al. · Oncotarget · 2018 · 72 citations · Full text

, , +13

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer

Ralph J. A. Maas, Janneke S. Hoogstad‐van Evert, Jolien M.R. Van der Meer et al. · OncoImmunology · 2020 · 69 citations · Full text

, , +17

Umbilical cord blood CD34<sup>+</sup>progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rg<sup>null</sup>mice

Janneke S. Hoogstad‐van Evert, Jeannette Cany, Dirk van den Brand et al. · OncoImmunology · 2017 · 68 citations · Full text

, , +17

Decitabine enhances targeting of AML cells by CD34+ progenitor-derived NK cells in NOD/SCID/IL2Rgnull mice

Jeannette Cany, Mieke W.H. Roeven, Janneke S. Hoogstad‐van Evert et al. · Blood · 2017 · 58 citations · Full text

, , +13

TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol

Miranda P. Steenbeek, Majke H.D. van Bommel, Joanna IntHout et al. · International Journal of Gynecological Cancer · 2023 · 48 citations · Full text

, , +11

1–5 of 10